crisnatol has been researched along with Nervous System Disorders in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cobb, PW; Craig, JB; Harman, GS; Havlin, KA; Koeller, J; Kuhn, JG; Luther, JS; Turner, JN; Tweedy, DA; Weiss, GR | 1 |
1 trial(s) available for crisnatol and Nervous System Disorders
| Article | Year |
|---|---|
Phase I evaluation of crisnatol (BWA770U mesylate) on a monthly extended infusion schedule.
Topics: Aged; Antineoplastic Agents; Chrysenes; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Nervous System Diseases; Propylene Glycols | 1991 |